FMC Q2 Results: EPS beats estimate, sales miss

1 min read | Published on 30 Jul 2026, 04:09 AM |Updated on 30 Jul 2026, 04:09 AM

Reviewed by

Riya DScanX News Team

Key Highlights

FMC Corporation delivered a mixed second-quarter report, with adjusted EPS of $0.26 beating the $0.22 estimate, but sales of $867.000 million missing the $905.171 million forecast. Year-over-year comparisons show a steep decline, with earnings down 62.32 percent and sales falling 17.43 percent from the same period last year.

*this image is generated using AI for illustrative purposes only.

FMC Corporation reported adjusted earnings per share of $0.26 for the second quarter, beating the analyst consensus estimate of $0.22 by 18.18 percent. Despite the earnings beat, the company’s financial performance showed significant year-over-year weakness, with earnings down 62.32 percent from $0.69 per share in the same period last year. The results highlight a divergence between profitability metrics and top-line growth, as sales failed to meet market expectations.

Quarterly sales came in at $867.000 million, missing the analyst consensus estimate of $905.171 million by 4.22 percent. This represents a substantial decline of 17.43 percent compared to sales of $1.050 billion recorded in the same quarter last year. The combination of a sales miss and a sharp drop in year-over-year earnings suggests underlying pressure on the company’s operational scale or pricing power during the period.

Financial Performance Overview

The following table outlines FMC’s key financial metrics for the second quarter against analyst estimates and prior-year figures:

Metric	Q2 Actual	Estimate	Variance vs Estimate	Prior Year Q2	YoY Change
Adjusted EPS	$0.26	$0.22	+18.18%	$0.69	-62.32%
Sales	$867.000M	$905.171M	-4.22%	$1.050B	-17.43%

What the Numbers Show

While FMC managed to deliver an adjusted EPS that exceeded immediate market expectations, the broader context reveals a challenging operating environment. The 62.32 percent year-over-year decline in earnings per share indicates that the current profit level is significantly lower than the previous year’s baseline. Simultaneously, the 17.43 percent drop in sales volume or value points to a contraction in demand or market share. The fact that EPS beat estimates despite this double-digit revenue decline suggests that cost-cutting measures or margin preservation efforts may have offset some of the top-line weakness, though the overall trajectory remains negative compared to the prior year.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

What specific cost-cutting measures or margin preservation strategies did FMC employ to achieve an EPS beat despite a 17.43% decline in sales?

How might the significant year-over-year drop in earnings impact FMC's dividend policy or share buyback programs in the coming quarters?

Which specific product segments or geographic regions contributed most to the sales miss, and are there signs of demand recovery in those areas?

FMC Q3 Results: Adj EPS Guidance $0.05-$0.13 vs $0.63 Est

1 min read | Published on 30 Jul 2026, 04:09 AM |Updated on 30 Jul 2026, 04:09 AM

Reviewed by

Naman SScanX News Team

Add as a preferred
source on Google

Key Highlights

FMC Corp's Q3 guidance reveals a significant downturn, with adjusted EPS projected at $0.05-$0.13 versus a $0.63 estimate. Sales of $840M-$900M also miss the $950.329M forecast, highlighting broader operational pressures.

*this image is generated using AI for illustrative purposes only.

FMC Corp (NYSE: FMC) issued third-quarter guidance that falls sharply short of market expectations, signaling potential headwinds in its agricultural and specialty chemical operations. The company projects adjusted earnings per share between $0.05 and $0.13, a significant miss against the $0.63 analyst estimate. This wide variance suggests underlying operational challenges or margin compression that investors had not fully priced into their models.

Revenue guidance also trails consensus estimates, with FMC forecasting sales between $840 million and $900 million for the quarter. This range sits well below the $950.329 million expected by analysts. The simultaneous miss on both top-line revenue and bottom-line profitability indicates a broad-based softness in demand or pricing power across its key segments during the period.

Guidance vs. Estimates

The divergence between FMC’s internal outlook and external analyst projections is substantial across both key financial metrics.

Metric	FMC Guidance	Analyst Estimate
Adjusted EPS	$0.05 – $0.13	$0.63
Sales	$840 million – $900 million	$950.329 million

What the Numbers Show

The most striking aspect of this guidance is the magnitude of the EPS miss. With the upper end of the guided range ($0.13) representing less than 21% of the estimated $0.63, the company is signaling a severe deterioration in profitability relative to expectations. This is not a minor variance but a structural shift in the quarterly outlook. When combined with revenue falling short by at least $50 million at the high end of the guidance range, it suggests that volume declines or price erosion are impacting the business more deeply than previously anticipated. Investors should monitor upcoming disclosures for details on segment-specific performance and cost-saving measures.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

What specific operational headwinds or margin compression factors in the agricultural and specialty chemical segments are driving this severe EPS miss?

How will FMC adjust its cost-saving measures or strategic initiatives to address the broader-than-expected softness in demand and pricing power?

Are analysts likely to downgrade their full-year earnings and revenue forecasts for FMC given the magnitude of this third-quarter guidance gap?